Hackathon to drive innovation and inspire developers to make a difference with their skills
WATERLOO, ON, July 12, 2024 /PRNewswire/ — OpenText™ (NASDAQ: OTEX), (TSX: OTEX) today announced that its 2024 Hackathon, Hacknosis: Sustainable MedTech, opens July 15, ending on August 15. The main objective of the virtual event is to develop a solution, using at least one OpenText API, that solves challenges in MedTech sustainability, social sustainable design and carbon accounting in technology.
According to the recent global OpenText IT Sustainability Report, 97 percent of organizations have adopted or plan to adopt sustainability initiatives. However, the biggest challenge in implementing these plans is the lack of proper tools and/or expertise, with only 50 percent of respondents using software to help track their IT carbon footprint. The 2024 Hackathon will address this issue with the requirement that participants develop technologies – apps, programs, etc. – that enhance existing OpenText solutions or lead to sustainability initiatives for organizations that are currently using OpenText solutions.
The Hackathon will award cash prizes for first, second and third place in three categories. The categories include:
“Hackathons are invaluable events that foster creativity and innovation, driving significant value across industries. By bringing together diverse groups of developers, designers, and problem-solvers, hackathons create a collaborative environment where fresh ideas and unique solutions can be created,” said John Radko, senior vice president, Engineering, OpenText. “These events encourage participants to think outside the box and tackle real-world challenges, often resulting in groundbreaking technologies and applications. The rapid prototyping and agile development practices inherent to hackathons accelerate the innovation cycle, transforming novel concepts into viable solutions that drive long-term value and growth.”
The OpenText 2023 Hackathon, themed Hacknosis: Optimizing Patient Experiences, saw five winners, including AllegroGraph who developed PatientGraph, an AI-driven clinical insight solution that enables healthcare providers to simplify data presentation to doctors, administrators and patients. PatientGraph demonstrates a real-world value of leveraging the AI capabilities within the OpenText Aviator Thrust API to reduce complexity for doctors and administrators to achieve better patient outcomes. PatientGraph has just been released to the market, and is now available on the OpenText Marketplace.
This year’s winners will be announced on the Hacknosis: Sustainable MedTech page in September 2024. Winning technologies and the challenges faced will be highlighted during a series of events in late 2024 and early 2025. More information and registration can be found here.
Additional resources
About OpenText
OpenText™ is the leading Information Management software and services company in the world. We help organizations solve complex global problems with a comprehensive suite of Business Clouds, Business AI, and Business Technology. For more information about OpenText (NASDAQ/TSX: OTEX), please visit us at www.opentext.com.
Connect with us:
OpenText CEO Mark Barrenechea’s blog
Certain statements in this press release may contain words considered forward-looking statements or information under applicable securities laws. These statements are based on OpenText’s current expectations, estimates, forecasts and projections about the operating environment, economies and markets in which the company operates. These statements are subject to important assumptions, risks and uncertainties that are difficult to predict, and the actual outcome may be materially different. OpenText’s assumptions, although considered reasonable by the company at the date of this press release, may prove to be inaccurate and consequently its actual results could differ materially from the expectations set out herein. For additional information with respect to risks and other factors which could occur, see OpenText’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other securities filings with the SEC and other securities regulators. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Unless otherwise required by applicable securities laws, OpenText disclaims any intention or obligations to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Further, readers should note that we may announce information using our website, press releases, securities law filings, public conference calls, webcasts and the social media channels identified on the Investors section of our website (https://investors.opentext.com). Such social media channels may include the Company’s or our CEO’s blog, Twitter account or LinkedIn account. The information posted through such channels may be material. Accordingly, readers should monitor such channels in addition to our other forms of communication.
Copyright © 2024 OpenText. All Rights Reserved. Trademarks owned by OpenText. One or more patents may cover this product(s). For more information, please visit https://www.opentext.com/patents
OTEX-G
SOURCE Open Text Corporation
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…